Vahid Salimi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Systematic Review

Pulmonary Embolism

Inferior Vena Cava

Top Venues

BMC infectious diseases

Journal of medical virology

Reviews in medical virology

Future virology

This page only lists publications with an associated author ORCID identifier.

Publications

Masoumeh Tavakoli-Yaraki, Aida Abbasi, Fatemeh Nejat Pishkenari, Saeed Baranipour, Alireza Jahangirifard, Seyed Bashir Mirtajani, Zahra Noorani Mejareh, Mohammad Amin Vaezi, Jila Yavarian, Bahare Abdollahi, Talat Mokhtari-Azad, Vahid Salimi
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection. BMC infectious diseases 24 (1) (2024)
Zahra Heydarifard, Ardalan Maleki Chegeni, Fatemeh Heydarifard, Bahram Nikmanesh, Vahid Salimi
An overview of SARS-CoV2 natural infections in companion animals: A systematic review of the current evidence. Reviews in medical virology 34 (1) (2024)
Fateme Ghafoori, Talat Mokhtari-Azad, Abbas Rahimi Foroushani, Mohammad Farahmand, Azade Shadab, Vahid Salimi
Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory. BMC infectious diseases 24 (1) (2024)
Masoumeh Tavakoli-Yaraki, Aida Abbasi, Fatemeh Nejat Pishkenari, Saeed Baranipour, Alireza Jahangirifard, Seyed Bashir Mirtajani, Zahra Noorani Mejareh, Mohammad Amin Vaezi, Jila Yavarian, Bahare Abdollahi, Talat Mokhtari-Azad, Vahid Salimi
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection. BMC infectious diseases 24 (1) (2024)
Fateme Ghafoori, Talat Mokhtari-Azad, Abbas Rahimi Foroushani, Mohammad Farahmand, Azade Shadab, Vahid Salimi
Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory. BMC infectious diseases 24 (1) (2024)
Zahra Heydarifard, Ardalan Maleki Chegeni, Fatemeh Heydarifard, Bahram Nikmanesh, Vahid Salimi
An overview of SARS-CoV2 natural infections in companion animals: A systematic review of the current evidence. Reviews in medical virology 34 (1) (2024)
Masoumeh Tavakoli-Yaraki, Aida Abbasi, Fatemeh Nejat Pishkenari, Saeed Baranipour, Alireza Jahangirifard, Seyed Bashir Mirtajani, Zahra Noorani Mejareh, Mohammad Amin Vaezi, Jila Yavarian, Bahare Abdollahi, Talat Mokhtari-Azad, Vahid Salimi
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection. BMC infectious diseases 24 (1) (2024)
Masoumeh Tavakoli-Yaraki, Aida Abbasi, Fatemeh Nejat Pishkenari, Saeed Baranipour, Alireza Jahangirifard, Seyed Bashir Mirtajani, Zahra Noorani Mejareh, Mohammad Amin Vaezi, Jila Yavarian, Bahare Abdollahi, Talat Mokhtari-Azad, Vahid Salimi
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection. BMC infectious diseases 24 (1) (2024)
Fateme Ghafoori, Talat Mokhtari-Azad, Abbas Rahimi Foroushani, Mohammad Farahmand, Azade Shadab, Vahid Salimi
Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory. BMC infectious diseases 24 (1) (2024)
Fateme Ghafoori, Talat Mokhtari-Azad, Abbas Rahimi Foroushani, Mohammad Farahmand, Azade Shadab, Vahid Salimi
Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory. BMC infectious diseases 24 (1) (2024)
Akram Sadat Ahmadi, Nazanin-Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Vahid Salimi, Ahmad Nejati, Talat-Mokhtari Azad, Jila Yavarian
SARS-CoV-2 in patient with protein C deficiency: A case report. Clinical case reports 11 (10) (2023)
Akram Sadat Ahmadi, Sevrin Zadheidar, Kaveh Sadeghi, Ahmad Nejati, Vahid Salimi, Mahboubeh Hajiabdolbaghi, Talat-Mokhtari Azad, Jila Yavarian
SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment. Journal of medical virology 95 (6) (2023)
Forough Tavakoli, Jila Yavarian, Nazanin-Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Nastaran Ghavami, Vahid Salimi, Talat-Mokhtari Azad
Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens. Future virology (2022)
Leila Mohebi, Hassan Karami, Negar Mirsalehi, Nima Hoveidi Ardestani, Jila Yavarian, Maysam Mard-Soltani, Talat Mokhatri-Azad, Vahid Salimi
A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022. Journal of medical virology 94 (12) (2022)
Alireza Tahamtan, Sjanna Besteman, Saeed Samadizadeh, Mostafa Rastegar, Louis Bont, Vahid Salimi
Neutrophils in respiratory syncytial virus infection: From harmful effects to therapeutic opportunities. British journal of pharmacology 178 (3) (2020)